중금속 중독 치료제 시장 보고서(2025년)

Heavy metal poisoning drugs are chelating agents that treat toxicity caused by metals like lead, mercury, arsenic, and cadmium. These drugs bind to harmful metals in the bloodstream, forming complexes that the body can safely eliminate through urine or feces. Their primary purpose is to lower metal levels in the body and prevent damage to organs.

The main products in this category include ALN-TMP, deferasirox, deferoxamine mesylate, emeramide, and others. ALN-TMP is an experimental RNA interference (RNAi) therapy aimed at reducing the production of specific proteins involved in heavy metal metabolism. It is applied in cases of arsenic, chromium, copper, lead toxicity, among others, and is utilized by hospitals, clinics, home healthcare providers, and poison control centers.

The heavy metal poisoning drugs market research report is one of a series of new reports from The Business Research Company that provides heavy metal poisoning drugs market statistics, including heavy metal poisoning drugs industry global market size, regional shares, competitors with a heavy metal poisoning drugs market share, detailed heavy metal poisoning drugs market segments, market trends and opportunities, and any further data you may need to thrive in the heavy metal poisoning drugs industry. This heavy metal poisoning drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The heavy metal poisoning drugs market size has grown strongly in recent years. It will grow from $1.34 billion in 2024 to $1.45 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth during the historic period can be attributed to increased industrial pollution, higher occupational exposure in the mining and manufacturing sectors, greater awareness and diagnosis of heavy metal toxicity, expanded use of chelation therapy, and the implementation of government regulations focused on environmental and workplace safety.

The heavy metal poisoning drugs market size is expected to see strong growth in the next few years. It will grow to $1.94 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to the increasing occurrence of environmental disasters, rising demand for pediatric heavy metal detoxification treatments, expansion into emerging markets, and the incorporation of heavy metal screening into preventive healthcare programs. Key trends anticipated during this period include the use of nanoparticle-based drug delivery systems, development of chelators with enhanced selectivity and reduced toxicity, application of gene editing and RNA therapies for detoxification, integration of artificial intelligence (AI) to personalize treatment plans, and advancements in biosensor technology for real-time detection and monitoring of heavy metals.

The rising industrialization is anticipated to drive the growth of the heavy metal poisoning drugs market in the coming years. Industrialization refers to the transition of an economy from being primarily agricultural to one centered around the manufacturing of goods and services. This trend is fueled by rapid urban development and infrastructure expansion, which create favorable conditions for business growth and economic advancement. Heavy metal poisoning drugs contribute to industrialization by safeguarding workers' health, minimizing toxic exposure risks, and supporting compliance with safety regulations-ultimately enhancing productivity and workplace safety. For example, in September 2024, the Office for National Statistics, a UK-based government agency, reported that the total value of UK manufacturers' product sales reached $574.6 billion (£456.1 billion) in 2023, an increase of approximately $21.7 billion (£17.2 billion), or 3.9%, from $553.2 billion (£438.9 billion) in 2022. Thus, the growing industrialization is propelling the heavy metal poisoning drugs market forward.

Leading companies in the heavy metal poisoning drugs market are concentrating on the development of innovative treatments, such as antidotes for lead poisoning, to improve therapeutic effectiveness, minimize side effects, and address the growing rates of environmental and occupational exposure to toxic metals. These antidotes, typically chelating agents, work by binding to lead in the bloodstream and facilitating its excretion through urine. For example, in August 2023, Rising Pharmaceuticals, a US-based pharmaceutical firm, introduced edetate calcium disodium injection, an antidote used to treat lead poisoning in both children and adults. This injectable chelating agent is effective in lowering lead levels in the blood and tissues and is particularly vital for treating severe cases like lead encephalopathy.

In October 2024, the Biomedical Advanced Research and Development Authority (BARDA), a U.S.-based research agency, partnered with HOPO Therapeutics to support the development of an oral chelating agent for treating heavy metal poisoning. The goal of this collaboration is to advance HOPO-101 toward approval by the Food and Drug Administration (FDA) as an oral countermeasure for both radioactive and heavy metal exposure, thereby strengthening preparedness for radiological emergencies and addressing broader public health concerns such as lead poisoning. HOPO Therapeutics is a U.S.-based clinical-stage pharmaceutical company focused on developing best-in-class, orally available therapies for heavy metal toxicity.

Major players in the heavy metal poisoning drugs market are Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals, Lupin Pharmaceuticals Inc., Zydus Cadila, Aristo Pharmaceuticals Pvt. Ltd., Medopharm Pvt. Ltd., Cayman Chemical, Recordati Rare Diseases Inc., Midas Pharma GmbH, EmeraMed Limited, Ambrosia Remedies Pvt. Ltd., SGPharma Pvt. Ltd., Nouryon, Actavis Pharma, Captura Biopharma, Hope Pharmaceuticals, HOPO Therapeutics Inc., and Triveni Interchem Pvt. Ltd.

North America was the largest region in the heavy metal poisoning drugs market in 2024. The regions covered in heavy metal poisoning drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the heavy metal poisoning drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The heavy metal poisoning drugs market consists of sales of dithiol chelating agents, aminopolycarboxylic acid chelators, amino acid-derived chelators, and hydroxamic acid derivatives. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Heavy Metal Poisoning Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on heavy metal poisoning drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for heavy metal poisoning drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The heavy metal poisoning drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: ALN-TMP; Deferasirox; Deferoxamine Mesylate; Emeramide; Other Product Types
• 2) By Application: Arsenic Toxicity; Chromium Toxicity; Copper Toxicity; Lead Toxicity; Other Applications
• 3) By End-User: Hospitals; Clinics; Home Healthcare; Poison Control Centers
• Subsegments:
• 1) By ALN-TMP: Small Interfering RNA (siRNA)-Based Chelation Therapies; Targeted RNA Interference Mechanisms; Intravenous Formulations; Hepatic Iron Overload Applications
• 2) By Deferasirox: Oral Tablet Formulations; Dispersible Tablets (DT); Generic Deferasirox Products; Iron Overload From Blood Transfusions; Beta-Thalassemia Related Use
• 3) By Deferoxamine Mesylate: Intramuscular Injections; Subcutaneous Infusion Pumps; Iron Poisoning Emergency Kits; Aluminum Toxicity In Dialysis Patients; Pediatric And Adult Formulations
• 4) By Emeramide: Mercury-Specific Chelation; Oral Capsule Form; Lipophilic Chelators; Environmental Toxic Exposure Applications; Investigational Therapies
• 5) By Other Product Types: Dimercaprol (BAL); Dimercaptosuccinic Acid (DMSA); 2,3-Dimercapto-1-Propanesulfonic Acid (DMPS); Penicillamine; Calcium Disodium Ethylenediaminetetraacetate (EDTA)
• Companies Mentioned: Sun Pharmaceutical Industries Ltd.; Aurobindo Pharma Ltd.; Dr. Reddy's Laboratories Ltd.; Hikma Pharmaceuticals; Lupin Pharmaceuticals Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Heavy Metal Poisoning Drugs Market Characteristics

3. Heavy Metal Poisoning Drugs Market Trends And Strategies

4. Heavy Metal Poisoning Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Heavy Metal Poisoning Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Heavy Metal Poisoning Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Heavy Metal Poisoning Drugs Market Growth Rate Analysis
• 5.4. Global Heavy Metal Poisoning Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Heavy Metal Poisoning Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Heavy Metal Poisoning Drugs Total Addressable Market (TAM)

6. Heavy Metal Poisoning Drugs Market Segmentation

• 6.1. Global Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• ALN-TMP
• Deferasirox
• Deferoxamine Mesylate
• Emeramide
• Other Product Types
• 6.2. Global Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Arsenic Toxicity
• Chromium Toxicity
• Copper Toxicity
• Lead Toxicity
• Other Applications
• 6.3. Global Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Home Healthcare
• Poison Control Centers
• 6.4. Global Heavy Metal Poisoning Drugs Market, Sub-Segmentation Of ALN-TMP, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small Interfering RNA (siRNA)-Based Chelation Therapies
• Targeted RNA Interference Mechanisms
• Intravenous Formulations
• Hepatic Iron Overload Applications
• 6.5. Global Heavy Metal Poisoning Drugs Market, Sub-Segmentation Of Deferasirox, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Tablet Formulations
• Dispersible Tablets (DT)
• Generic Deferasirox Products
• Iron Overload From Blood Transfusions
• Beta-Thalassemia Related Use
• 6.6. Global Heavy Metal Poisoning Drugs Market, Sub-Segmentation Of Deferoxamine Mesylate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intramuscular Injections
• Subcutaneous Infusion Pumps
• Iron Poisoning Emergency Kits
• Aluminum Toxicity In Dialysis Patients
• Pediatric And Adult Formulations
• 6.7. Global Heavy Metal Poisoning Drugs Market, Sub-Segmentation Of Emeramide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mercury-Specific Chelation
• Oral Capsule Form
• Lipophilic Chelators
• Environmental Toxic Exposure Applications
• Investigational Therapies
• 6.8. Global Heavy Metal Poisoning Drugs Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dimercaprol (BAL)
• Dimercaptosuccinic Acid (DMSA)
• 2,3-Dimercapto-1-Propanesulfonic Acid (DMPS)
• Penicillamine
• Calcium Disodium Ethylenediaminetetraacetate (EDTA)

7. Heavy Metal Poisoning Drugs Market Regional And Country Analysis

• 7.1. Global Heavy Metal Poisoning Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Heavy Metal Poisoning Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Heavy Metal Poisoning Drugs Market

• 8.1. Asia-Pacific Heavy Metal Poisoning Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Heavy Metal Poisoning Drugs Market

• 9.1. China Heavy Metal Poisoning Drugs Market Overview
• 9.2. China Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Heavy Metal Poisoning Drugs Market

• 10.1. India Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Heavy Metal Poisoning Drugs Market

• 11.1. Japan Heavy Metal Poisoning Drugs Market Overview
• 11.2. Japan Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Heavy Metal Poisoning Drugs Market

• 12.1. Australia Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Heavy Metal Poisoning Drugs Market

• 13.1. Indonesia Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Heavy Metal Poisoning Drugs Market

• 14.1. South Korea Heavy Metal Poisoning Drugs Market Overview
• 14.2. South Korea Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Heavy Metal Poisoning Drugs Market

• 15.1. Western Europe Heavy Metal Poisoning Drugs Market Overview
• 15.2. Western Europe Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Heavy Metal Poisoning Drugs Market

• 16.1. UK Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Heavy Metal Poisoning Drugs Market

• 17.1. Germany Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Heavy Metal Poisoning Drugs Market

• 18.1. France Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Heavy Metal Poisoning Drugs Market

• 19.1. Italy Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Heavy Metal Poisoning Drugs Market

• 20.1. Spain Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Heavy Metal Poisoning Drugs Market

• 21.1. Eastern Europe Heavy Metal Poisoning Drugs Market Overview
• 21.2. Eastern Europe Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Heavy Metal Poisoning Drugs Market

• 22.1. Russia Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Heavy Metal Poisoning Drugs Market

• 23.1. North America Heavy Metal Poisoning Drugs Market Overview
• 23.2. North America Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Heavy Metal Poisoning Drugs Market

• 24.1. USA Heavy Metal Poisoning Drugs Market Overview
• 24.2. USA Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Heavy Metal Poisoning Drugs Market

• 25.1. Canada Heavy Metal Poisoning Drugs Market Overview
• 25.2. Canada Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Heavy Metal Poisoning Drugs Market

• 26.1. South America Heavy Metal Poisoning Drugs Market Overview
• 26.2. South America Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Heavy Metal Poisoning Drugs Market

• 27.1. Brazil Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Heavy Metal Poisoning Drugs Market

• 28.1. Middle East Heavy Metal Poisoning Drugs Market Overview
• 28.2. Middle East Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Heavy Metal Poisoning Drugs Market

• 29.1. Africa Heavy Metal Poisoning Drugs Market Overview
• 29.2. Africa Heavy Metal Poisoning Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Heavy Metal Poisoning Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Heavy Metal Poisoning Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Heavy Metal Poisoning Drugs Market Competitive Landscape And Company Profiles

• 30.1. Heavy Metal Poisoning Drugs Market Competitive Landscape
• 30.2. Heavy Metal Poisoning Drugs Market Company Profiles
  • 30.2.1. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Aurobindo Pharma Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Dr. Reddy's Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Hikma Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Lupin Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Heavy Metal Poisoning Drugs Market Other Major And Innovative Companies

• 31.1. Zydus Cadila
• 31.2. Aristo Pharmaceuticals Pvt. Ltd.
• 31.3. Medopharm Pvt. Ltd.
• 31.4. Cayman Chemical
• 31.5. Recordati Rare Diseases Inc.
• 31.6. Midas Pharma GmbH
• 31.7. EmeraMed Limited
• 31.8. Ambrosia Remedies Pvt. Ltd.
• 31.9. SGPharma Pvt. Ltd.
• 31.10. Nouryon
• 31.11. Actavis Pharma
• 31.12. Captura Biopharma
• 31.13. Hope Pharmaceuticals
• 31.14. HOPO Therapeutics Inc.
• 31.15. Triveni Interchem Pvt. Ltd.

32. Global Heavy Metal Poisoning Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Heavy Metal Poisoning Drugs Market

34. Recent Developments In The Heavy Metal Poisoning Drugs Market

35. Heavy Metal Poisoning Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Heavy Metal Poisoning Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Heavy Metal Poisoning Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Heavy Metal Poisoning Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer